INTRODUCTION: Metabolic dysfunction-associated steatohepatitis (MASH) is a significant liver disease that can lead to cirrhosis and liver cancer. Accurate assessment of liver fibrosis is crucial for diagnosis, prognosis, and informed treatment decision-making. Staging of liver fibrosis in MASH is based on Kleiner's score, which categorizes fibrosis based on its location within the liver as observed microscopically. This scoring system is part of a standard clinical research network and relies heavily on the expertise of pathologists. METHODS: This study utilized Sirius Red-stained whole slide images of liver tissue obtained from various MASH animal models to develop deep learning (DL) models for scoring liver fibrosis, with a focus on the criteria outlined in Kleiner's score. We created a trainable and testable dataset of whole-slide images of the liver, consisting of 999,711 patch images derived from 914 whole-slide images. The performance of the multi-class classification model was evaluated using the kappa statistic, area under the precision-recall curve (AUPRC), area under the receiver operating characteristic curve (AUROC), and Matthews correlation coefficient (MCC). RESULTS: To address challenges in clinical subclassification, a 5-class classification model was initially applied; the model achieved moderate agreement. A more refined 7-class model was subsequently developed, which outperformed the 5-class classification model. The enhanced subclassification significantly improved classification performance, as evidenced by the superior AUROC and AUPRC values of the 7-class model. DISCUSSION: This study highlights that DL models for scoring liver fibrosis can support expert pathologists in staging liver fibrosis in preclinical animal studies.
Deep learning-based method for grading histopathological liver fibrosis in rodent models of metabolic dysfunction-associated steatohepatitis.
基于深度学习的代谢功能障碍相关脂肪性肝炎啮齿动物模型肝组织病理学纤维化分级方法
阅读:8
作者:Ko Soo Min, Shin Jae-Ik, Hong Yiyu, Kim Hyunji, Sohn Insuk, Lee Ji-Young, Han Hyo-Jeong, Jeong Da Som, Lee Yerin, Son Woo-Chan
| 期刊: | Frontiers in Medicine | 影响因子: | 3.000 |
| 时间: | 2025 | 起止号: | 2025 Jul 4; 12:1629036 |
| doi: | 10.3389/fmed.2025.1629036 | 研究方向: | 代谢 |
特别声明
1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。
4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。
